Archives of Neuroscience

Published by: Kowsar

A Review on Stem Cell Therapy in Cerebral Palsy with a Focus on Motor Function Improvement

Farzad Ashrafi 1 , * , Ali-Reza Zali 1 , Hossein Pakdaman 2 , 3 , Behdad Behnam 1 , Mehran Arab Ahmadi 1 , Ali Amini Harandi 2 and Saeed Oraee-Yazdani 1 , 4
Authors Information
1 Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Department of Neurology, Loghman Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Department of Stem Cell Biology, Stem Cell Technology Research Center, Tehran, Iran
Article information
  • Archives of Neuroscience: January 2018, 5 (1); e59387
  • Published Online: January 10, 2018
  • Article Type: Review Article
  • Received: August 2, 2017
  • Revised: November 12, 2017
  • Accepted: December 9, 2017
  • DOI: 10.5812/archneurosci.59387

To Cite: Ashrafi F, Zali A, Pakdaman H, Behnam B, Arab Ahmadi M, et al. A Review on Stem Cell Therapy in Cerebral Palsy with a Focus on Motor Function Improvement, Arch Neurosci. 2018 ; 5(1):e59387. doi: 10.5812/archneurosci.59387.

Copyright © 2017, Archives of Neuroscience. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Methods
3. Results
4. Discussion
  • 1. Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, et al. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol. 2005;47(8):571-6. doi: 10.1017/s001216220500112x.
  • 2. Shevell MI, Bodensteiner JB. Cerebral palsy: defining the problem. Semin Pediatr Neurol. 2004;11(1):2-4. [PubMed: 15132247].
  • 3. Jacobsson B, Hagberg G. Antenatal risk factors for cerebral palsy. Best Pract Res Clin Obstet Gynaecol. 2004;18(3):425-36. doi: 10.1016/j.bpobgyn.2004.02.011. [PubMed: 15183137].
  • 4. Odding E, Roebroeck ME, Stam HJ. The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil Rehabil. 2006;28(4):183-91. doi: 10.1080/09638280500158422. [PubMed: 16467053].
  • 5. Russman BS, Ashwal S. Evaluation of the child with cerebral palsy. Semin Pediatr Neurol. 2004;11(1):47-57. [PubMed: 15132253].
  • 6. Moster D, Wilcox AJ, Vollset SE, Markestad T, Lie RT. Cerebral palsy among term and postterm births. JAMA. 2010;304(9):976-82. doi: 10.1001/jama.2010.1271. [PubMed: 20810375].
  • 7. Strauss D, Shavelle R, Reynolds R, Rosenbloom L, Day S. Survival in cerebral palsy in the last 20 years: signs of improvement?. Dev Med Child Neurol. 2007;49(2):86-92. doi: 10.1111/j.1469-8749.2007.00086.x. [PubMed: 17253993].
  • 8. Hemming K, Hutton JL, Pharoah PO. Long-term survival for a cohort of adults with cerebral palsy. Dev Med Child Neurol. 2006;48(2):90-5. doi: 10.1017/S0012162206000211. [PubMed: 16417662].
  • 9. Quality Standards Subcommittee of the American Academy of N, the Practice Committee of the Child Neurology S, Delgado MR, Hirtz D, Aisen M, Ashwal S, et al. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2010;74(4):336-43. doi: 10.1212/WNL.0b013e3181cbcd2f. [PubMed: 20101040].
  • 10. Perlman JM. Intrapartum hypoxic-ischemic cerebral injury and subsequent cerebral palsy: medicolegal issues. Pediatrics. 1997;99(6):851-9. doi: 10.1542/peds.99.6.851. [PubMed: 9164779].
  • 11. Dailey T, Tajiri N, Kaneko Y, Borlongan CV. Regeneration of neuronal cells following cerebral injury. Front Neurol Neurosci. 2013;32:54-61. doi: 10.1159/000346407. [PubMed: 23859963].
  • 12. Hess DC, Borlongan CV. Stem cells and neurological diseases. Cell Prolif. 2008;41 Suppl 1:94-114. doi: 10.1111/j.1365-2184.2008.00486.x. [PubMed: 18181951].
  • 13. Carroll JE, Borlongan CV. Adult stem cell therapy for acute brain injury in children. CNS Neurol Disord Drug Targets. 2008;7(4):361-9. [PubMed: 18991664].
  • 14. Jensen A, Hamelmann E. First autologous cell therapy of cerebral palsy caused by hypoxic-ischemic brain damage in a child after cardiac arrest-individual treatment with cord blood. Case Rep Transplant. 2013;2013:951827. doi: 10.1155/2013/951827. [PubMed: 23762741].
  • 15. Chen G, Wang Y, Xu Z, Fang F, Xu R, Wang Y, et al. Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy. J Transl Med. 2013;11:21. doi: 10.1186/1479-5876-11-21. [PubMed: 23351389].
  • 16. Wang X, Cheng H, Hua R, Yang J, Dai G, Zhang Z, et al. Effects of bone marrow mesenchymal stromal cells on gross motor function measure scores of children with cerebral palsy: a preliminary clinical study. Cytotherapy. 2013;15(12):1549-62. doi: 10.1016/j.jcyt.2013.06.001. [PubMed: 24100132].
  • 17. Mancias-Guerra C, Marroquin-Escamilla AR, Gonzalez-Llano O, Villarreal-Martinez L, Jaime-Perez JC, Garcia-Rodriguez F, et al. Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial. Cytotherapy. 2014;16(6):810-20. doi: 10.1016/j.jcyt.2014.01.008. [PubMed: 24642016].
  • 18. Zali A, Arab L, Ashrafi F, Mardpour S, Niknejhadi M, Hedayati-Asl AA, et al. Intrathecal injection of CD133-positive enriched bone marrow progenitor cells in children with cerebral palsy: feasibility and safety. Cytotherapy. 2015;17(2):232-41. doi: 10.1016/j.jcyt.2014.10.011. [PubMed: 25593079].
  • 19. Shroff G, Gupta A, Barthakur JK. Therapeutic potential of human embryonic stem cell transplantation in patients with cerebral palsy. J Transl Med. 2014;12:318. doi: 10.1186/s12967-014-0318-7. [PubMed: 25496119].
  • 20. Li M, Yu A, Zhang F, Dai G, Cheng H, Wang X, et al. Treatment of one case of cerebral palsy combined with posterior visual pathway injury using autologous bone marrow mesenchymal stem cells. J Transl Med. 2012;10:100. doi: 10.1186/1479-5876-10-100. [PubMed: 22607263].
  • 21. Faulkner SD, Ruff CA, Fehlings MG. The potential for stem cells in cerebral palsy--piecing together the puzzle. Semin Pediatr Neurol. 2013;20(2):146-53. doi: 10.1016/j.spen.2013.06.002. [PubMed: 23948689].
  • 22. Ruff CA, Faulkner SD, Fehlings MG. The potential for stem cell therapies to have an impact on cerebral palsy: opportunities and limitations. Dev Med Child Neurol. 2013;55(8):689-97. doi: 10.1111/dmcn.12166. [PubMed: 23680015].
  • 23. Purandare C, Shitole DG, Belle V, Kedari A, Bora N, Joshi M. Therapeutic potential of autologous stem cell transplantation for cerebral palsy. Case Rep Transplant. 2012;2012:825289. doi: 10.1155/2012/825289. [PubMed: 23259143].
  • 24. Park KI, Himes BT, Stieg PE, Tessler A, Fischer I, Snyder EY. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp Neurol. 2006;199(1):179-90. doi: 10.1016/j.expneurol.2006.03.016. [PubMed: 16714016].
  • 25. Iwanami A, Kaneko S, Nakamura M, Kanemura Y, Mori H, Kobayashi S, et al. Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res. 2005;80(2):182-90. doi: 10.1002/jnr.20436. [PubMed: 15772979].
  • 26. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25(11):2739-49. doi: 10.1634/stemcells.2007-0197. [PubMed: 17656645].
  • 27. Ma H, Yu B, Kong L, Zhang Y, Shi Y. Neural stem cells over-expressing brain-derived neurotrophic factor (BDNF) stimulate synaptic protein expression and promote functional recovery following transplantation in rat model of traumatic brain injury. Neurochem Res. 2012;37(1):69-83. doi: 10.1007/s11064-011-0584-1. [PubMed: 21901549].
  • 28. Hofstetter CP, Holmstrom NA, Lilja JA, Schweinhardt P, Hao J, Spenger C, et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci. 2005;8(3):346-53. doi: 10.1038/nn1405. [PubMed: 15711542].
  • 29. Lim JY, Park SI, Kim SM, Jun JA, Oh JH, Ryu CH, et al. Neural differentiation of brain-derived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and beta-catenin phosphorylation and following transplantation into the developing brain. Cell Transplant. 2011;20(11-12):1855-66. doi: 10.3727/096368910X557236. [PubMed: 21375801].
  • 30. Chekhonin VP, Lebedev SV, Volkov AI, Pavlov KA, Ter-Arutyunyants AA, Volgina NE, et al. Activation of expression of brain-derived neurotrophic factor at the site of implantation of allogenic and xenogenic neural stem (progenitor) cells in rats with ischemic cortical stroke. Bull Exp Biol Med. 2011;150(4):515-8. doi: 10.1007/s10517-011-1180-8. [PubMed: 22268055].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments